Canada's Competition Bureau closes two investigations into pharmaceutical patent litigation settlements
MLex Summary: Canada’s Competition Bureau announced that it has closed two recent investigations into potentially anticompetitive patent litigation settlement agreements involving pharmaceutical drugs. Evidence gathered during the investigations suggested that the...To view the full article, register now.
Already a subscriber? Click here to view full article